Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
734 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anthos Investigational Site 1443
Buenos Aires, Buenos Aires F.D., Argentina
Recruiting - Anthos Investigational Site 1463
Buenos Aires, Buenos Aires F.D., Argentina
Recruiting - Anthos Investigational Site 1444
Córdoba, Córdoba Province, Argentina
Active, not recruiting - Anthos Investigational Site 1439
Villa María, Córdoba Province, Argentina
Recruiting - Anthos Investigative Site 1411
Buenos Aires, Argentina
Recruiting - Anthos Investigative Site 1430
Buenos Aires, Argentina
Recruiting - Anthos Investigative Site 1409
Ciudad Autónoma Buenos Aires, Argentina
Recruiting - Anthos Investigative Site 1410
Ciudad Autónoma de Buenos Aire, Argentina
Recruiting - Anthos Investigative Site 1423
Ciudad Autónoma de Buenos Aire, Argentina
Recruiting - Anthos Investigative Site 1429
Coronel Suárez, Argentina
Recruiting - Anthos Investigative Site 1420
Corrientes, Argentina
Recruiting - Anthos Investigative Site 1407
Córdoba, Argentina
Recruiting - Anthos Investigative Site 1414
Córdoba, Argentina
Recruiting - Anthos Investigative Site 1418
Córdoba, Argentina
Recruiting - Anthos Investigative Site 1419
Córdoba, Argentina
Recruiting - Anthos Investigative Site 1424
Córdoba, Argentina
Recruiting - Anthos Investigative Site 1427
Córdoba, Argentina
Recruiting - Anthos Investigative Site 1431
Córdoba, Argentina
Recruiting - Anthos Investigative Site 1434
Córdoba, Argentina
Recruiting - Anthos Investigative Site 1402
La Plata, Argentina
Recruiting - Anthos Investigative Site 1417
Quilmes, Argentina
Recruiting - Anthos Investigative Site 1415
Ramos Mejía, Argentina
Recruiting - Anthos Investigative Site 1403
Salta, Argentina
Recruiting - Anthos Investigative Site 1425
San Luis, Argentina
Recruiting - Anthos Investigative Site 1426
San Martin, Argentina
Recruiting - Anthos Investigative Site 1404
San Miguel de Tucumán, Argentina
Recruiting - Anthos Investigative Site 1435
San Miguel de Tucumán, Argentina
Recruiting - Anthos Investigative Site 1436
San Nicolás, Argentina
Recruiting
- Anthos Investigative Site 1518
Aracaju, Brazil
Recruiting - Anthos Investigative Site 1507
Belo Horizonte, Brazil
Recruiting - Anthos Investigative Site 1516
Belo Horizonte, Brazil
Recruiting - Anthos Investigative Site 1527
Belo Horizonte, Brazil
Recruiting - Anthos Investigative Site 1528
Belo Horizonte, Brazil
Recruiting - Anthos Investigative Site 1505
Blumenau, Brazil
Recruiting - Anthos Investigative Site 1513
Blumenau, Brazil
Recruiting - Anthos Investigative Site 1535
Brasília, Brazil
Recruiting - Anthos Investigative Site 1501
Campina Grande do Sul, Brazil
Recruiting - Anthos Investigative Site 1503
Campinas, Brazil
Withdrawn - Anthos Investigative Site 1522
Campinas, Brazil
Recruiting - Anthos Investigative Site 1520
Campo Grande, Brazil
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Dec 2022
- Primary completion
- 31 Aug 2026
- Completion
- 31 Oct 2026
- Last update posted
- 31 Mar 2026
- Registered enrollment
- 1,900
- Registry id
- NCT05712200
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.